A2R-32095-83347
4 vaccinations
7 coded responses
14 check-ins
7 free-text entries
3 call cases
- Sex
- Male
- Age at first dose
- 61-65
- ZIP prefix
- 282 / NC
- Registered
- 2021-01-20
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-20
Registered in v-safe
-
2021-01-20
Dose 1 — Moderna
-
2021-01-22
Survey response — days 1–6 daily, dose 1MedDRA: Lymphadenopathy — Feeling: Good · Site: Pain, SwellingFree text: Cervical lymph nodes enlarged.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-23
- 2021-01-24
-
2021-01-29
Survey response — day 7, dose 1MedDRA: Unevaluable event — Feeling: GoodFree text: Appear to be experiencing a site reaction to Glateramir Acetate injection for MS.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-03
- 2021-02-10
-
2021-02-17
Dose 2 — Moderna
-
2021-03-03
Survey response — day 14, dose 2MedDRA: Diarrhoea, Nausea, Vomiting — Feeling: FairFree text: Nausea, one episode of vommiting, loose stool.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-10
-
2021-03-17
Survey response — day 28, dose 2MedDRA: Abdominal pain, Asthenia, Hot flush, Nausea — Feeling: Poor · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Nausea, abdominal cramps, hot flashes, and weakness.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-17
Report sent to call center — day 28, dose 2Get care from a doctor or other healthcare professional1 call case(s)
-
2021-03-24
Survey response — day 35, dose 2MedDRA: Abdominal discomfort, Diarrhoea, Muscle spasms, Nausea — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: GI distress. Nausea, loose stools, cramping.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-24
Report sent to call center — day 35, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-04-03
-
2021-08-19
Dose 3 — Moderna
- 2021-08-21
-
2021-11-18
Survey response — 3 months, dose 3MedDRA: Ageusia, Cough, Eye discharge, Eye infection, Headache, Oropharyngeal pain, Respiratory tract congestion, Sinusitis, Unevaluable event — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Symptoms: Sore throat, congestion, headache, cough, eye drainage, loss of taste, sinus infection, and eye infection. · Healthcare visit (other): RadiologyMedDRA releases: 2024-11 · check-in free text available
-
2021-11-18
Report sent to call center — 3 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
- 2021-11-19
-
2022-03-30
Dose 4 — Moderna
-
2022-06-29
Survey response — 3 months, dose 4MedDRA: Ageusia, Anosmia, Cough, Fatigue, Paranasal sinus hypersecretion, Respiratory tract congestion — Feeling: Fair · Be unable to work or attend schoolFree text: Cough, congestion, sinus drainage, significant fatigue, loss of smell and taste.MedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-20 | Moderna | |
| 2 | 2021-02-17 | Moderna | |
| 3 | 2021-08-19 | Moderna | No |
| 4 | 2022-03-30 | Moderna | No |
Call center
3 call center cases
3 unsuccessful
Free text
Release 2 — days 1–6 daily, dose 1
Systemic reaction (other): Cervical lymph nodes enlarged.
Release 3 — day 7, dose 1
Systemic reaction (other): Appear to be experiencing a site reaction to Glateramir Acetate injection for MS.
Release 5 — day 14, dose 2
Symptoms: Nausea, one episode of vommiting, loose stool.
Release 5 — day 28, dose 2
Symptoms: Nausea, abdominal cramps, hot flashes, and weakness.
Release 6 — day 35, dose 2
Symptoms: GI distress. Nausea, loose stools, cramping.
Release 10 — 3 months, dose 3
Symptoms: Sore throat, congestion, headache, cough, eye drainage, loss of taste, sinus infection, and eye infection.
Healthcare visit (other): Radiology
Release 12 — 3 months, dose 4
Symptoms: Cough, congestion, sinus drainage, significant fatigue, loss of smell and taste.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Unevaluable event | · | · | ✓ |
| SD | Abdominal discomfort | ✓ | ✓ | ✓ |
| SD | Abdominal pain | ✓ | ✓ | ✓ |
| SD | Ageusia | · | · | ✓ |
| SD | Anosmia | · | · | ✓ |
| SD | Asthenia | ✓ | ✓ | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Diarrhoea | ✓ | ✓ | ✓ |
| SD | Eye discharge | · | · | ✓ |
| SD | Eye infection | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Hot flush | ✓ | ✓ | ✓ |
| SD | Muscle spasms | ✓ | ✓ | ✓ |
| SD | Nausea | ✓ | ✓ | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Paranasal sinus hypersecretion | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Sinusitis | · | · | ✓ |
| SD | Vomiting | ✓ | ✓ | ✓ |
| SRO | Lymphadenopathy | ✓ | ✓ | ✓ |
| SRO | Unevaluable event | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release